logo

BEAM

Beam Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
3.30 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is BEAM a Good Buy Right Now?
  • Based on a composite score of 3.30/10, we rate BEAM as a Netural. Our analysis breaks down into 3.56/10 for Fundamentals, 1.86/10 for Technicals, and 3.88/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is BEAM undervalued or overvalued?
Technical Analysis of BEAM?
What is the analyst consensus for BEAM?